Market Research Report Store Portola Pharmaceuticals Inc (PTLA) – Pharmaceutica

Market Research Report Store has been recently published a fresh report"Portola Pharmaceuticals Inc (PTLA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile-Market Research Report Store＂.It is a professional and in-depth study. Complete Report Available at: @ https://www.marketresearchreportstore.com/shop/portola-pharmaceuticals-inc-ptla-pharmaceut icals-healthcare-deals-and-alliances-profile-2 Request a sample, click here [email protected] Description Portola Pharmaceuticals Inc (Portola) is a biopharmaceutical company that research and develops therapies. The company discovers and develops therapeutics for the treatment of oncology indications, cardiovascular, inflammation, and others. Its products include Betrixaban, an oral once-daily Factor Xa inhibitor anticoagulant that inhibits the activity of Factor Xa; andexanet alfa, a recombinant protein designed to reverse anticoagulant activity of both direct and indirect Factor Xa inhibitors; and cerdulatinib, an oral, dual Syk-JAK inhibitor in development to treat hematologic cancers. Portola provides compounds using biomarker and genetic approaches for clinical, regulatory and commercial potentially of therapies. The company offers patient care services in the areas of thrombosis, other hematologic disorders and inflammation. Portola is headquartered in South San Francisco, California, the US. Portola Pharmaceuticals Inc (PTLA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.